Can Infuvite (multivitamin additive) in D5W be administered concurrently with Clinimix E (amino‑acid parenteral nutrition)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Compatibility of Infuvite with D5W and Clinimix E

Yes, Infuvite can be added to D5W and this solution can be run concurrently with Clinimix E (amino acid parenteral nutrition), but they should NOT be mixed together in the same container. The safest approach is Y-site administration through separate lumens or sequential administration if venous access is limited.

Key Administration Principles

The FDA labeling for Infuvite explicitly states that it must be diluted in dextrose or saline solutions prior to intravenous administration and should never be given as a direct undiluted injection 1. This makes D5W an appropriate diluent vehicle.

Compatibility Considerations

Physical Compatibility Issues

When vitamins and amino acid solutions are combined:

  • Lipid-soluble vitamins (A, D, E, K) should ideally be added to lipid emulsions rather than amino acid solutions to increase vitamin stability and reduce losses 2
  • Vitamin A in particular experiences substantial losses when given with water-soluble solutions 2
  • The combination of vitamins with amino acid-dextrose solutions creates potential for chemical degradation, particularly of ascorbic acid (vitamin C) which is highly unstable and reacts with oxygen 3

Practical Administration Strategy

Recommended approach:

  1. Add Infuvite to D5W as directed per FDA labeling 1
  2. Administer through a separate Y-site or lumen from the Clinimix E
  3. Avoid mixing Infuvite-D5W directly into the Clinimix E bag

This separation prevents:

  • Calcium phosphate precipitation (a major concern with parenteral nutrition admixtures) 3, 4
  • Vitamin degradation from prolonged contact with amino acids 5, 3
  • Loss of vitamin A through adsorption 4

Critical Caveats

If you must use the same line:

  • Y-site co-administration is preferable to direct mixing 6, 7
  • Monitor for any visible precipitation or color changes
  • Be aware that compatibility data for specific PN formulations with vitamins is limited and highly variable based on exact composition 6, 7
  • Do not extrapolate compatibility between different PN formulations - what works with one amino acid product may not work with another 6

Optimal practice per guidelines: Vitamins should be administered daily, and lipid-soluble vitamins given simultaneously with lipid emulsions when available 2. If Clinimix E contains lipids, consider whether adding vitamins to that component would be more appropriate than using D5W as the carrier.

The evidence strongly suggests that while technically feasible to run these through the same access point via Y-site, keeping vitamin and amino acid solutions separate until the point of infusion maximizes vitamin stability and minimizes compatibility risks 2, 3, 4.

Related Questions

What is the recommended dose of injectable multivitamin infusion (MVI) for administration?
In neonatal parenteral nutrition, can Aminoven (2.5% amino‑acid solution) be administered directly as a separate infusion or mixed with dextrose and lipid solutions, and what are the compatibility and infusion‑rate considerations?
How do Aminoven (10% amino‑acid solution) and Aminoplasmal (8% amino‑acid solution) compare regarding composition, electrolyte content, and suitability for adult parenteral nutrition?
What are the contraindications to providing maintenance calcium and magnesium in parenteral nutrition?
How should an amino‑acid infusion be administered and dosed in total parenteral nutrition?
What are the recommended management steps for a 75‑year‑old woman with osteopenia of the left hip?
In an adult patient with atrial fibrillation, hypertension, and heart failure with preserved ejection fraction (EF 55‑60 %), who is already taking torsemide, spironolactone, and lisinopril but still has uncontrolled blood pressure (150/80 mm Hg) and bilateral lower‑leg edema, what non‑diuretic heart medication can be added to improve his condition?
In a healthy 16‑year‑old female with a 2 cm left‑lobe hepatic hemangioma, could it cause elevated liver enzymes?
Should a repeat complete blood count (CBC) be performed for a patient with mild leukocytosis and neutrophilia?
With a TSH of 0.331 mIU/L, should the test be repeated in 6–8 weeks?
What is the recommended treatment for post‑febrile neuralgia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.